<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.
Contact Us
Contact Us

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Preclinical models to study nerve damage and pain from chemotherapy.

SPEAK WITH A SCIENTIST

mdbiosciences-neurology-leading-preclinical-CRO-1

Preclinical Efficacy Models of Chemotherapy-Induced Pain

Neurotoxicity and peripheral neuropathy are common side effects of chemotherapy, often limiting the dose needed for optimal anti-tumor effects. MD Biosciences offers preclinical models of chemotherapy-induced neuropathic pain, providing reliable tools to evaluate novel interventions and better understand mechanisms of nerve damage and pain associated with chemotherapy.
Speak with a scientist

Assessments

MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.
behavior

Behavior 

Conduct extensive pain, sensory, motor, and cognitive behavioral testing.

biomarker

Biomarkers

Explore inflammatory and pain biomarkers in disease-specific tissues.

histology

Histology

Characterize tissue and cellular changes in disease, pain, and neurodegeneration.

Explore our Resources

READY TO DISCUSS YOUR PROGRAM?

MD Biosciences is your dedicated partner in drug development, offering tailored study designs, translational models, and comprehensive endpoints. With short lead times, competitive pricing, and deep scientific expertise, we help move your pipeline forward efficiently.

Request Proposal